| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $257.9M | — | +22.4% |
| Cost of Revenue | $113.2M | — | +39.3% |
| Gross Profit | $144.7M | — | +11.8% |
| R&D Expense | $48.8M | — | +23.3% |
| SG&A Expense | $37.6M | — | +14.7% |
| Operating Income | $36.6M | — | -2.8% |
| Interest Expense | $5.7M | — | +4414.3% |
| Pre-tax Income | $24.5M | — | -40.8% |
| Income Tax | $8.7M | — | +174.7% |
| Net Income | $15.8M | — | -58.7% |
| EPS (Basic) | $0.17 | — | -59.5% |
| EPS (Diluted) | $0.15 | — | -61.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $741.4M | +191.3% | +105.7% |
| Accounts Receivable | $105.5M | +16.0% | +37.7% |
| Current Assets | $944.3M | +121.2% | +97.0% |
| Total Assets | $2.57B | +39.9% | +56.6% |
| Current Liabilities | $647.0M | +4.4% | +226.2% |
| Long-term Debt | $919.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $46.9M | — | -26.8% |
| Capital Expenditures | $40.0M | — | -35.5% |
| Investing Cash Flow | -$60.6M | — | +6.8% |
| Financing Cash Flow | $500.6M | — | +845.2% |
| Free Cash Flow | $6.9M | — | +225.8% |
| -38.2% |
| Total Liabilities | $1.68B | -9.8% | -9.1% |
| Stockholders' Equity | $887.4M | +3193.0% | +521.1% |